1 / 2

EPIC: Balloon Angioplasty

Placebo + heparin (ACT  300 sec) (n=696). Abciximab 0.25mg/kg bolus + heparin (ACT  300 sec) (n=395). Abciximab 0.25mg/kg bolus / 10 µg/kg infusion + heparin (ACT  300 sec) (n=708). EPIC: Balloon Angioplasty. Primary Endpoint: Death, MI, UTVR at 30 days. 4.5%  ( P <0.004).

austin-rosales
Télécharger la présentation

EPIC: Balloon Angioplasty

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Placebo + heparin (ACT  300 sec)(n=696) Abciximab 0.25mg/kg bolus + heparin (ACT  300 sec)(n=395) Abciximab 0.25mg/kg bolus / 10 µg/kg infusion + heparin (ACT  300 sec)(n=708) EPIC: Balloon Angioplasty Primary Endpoint: Death, MI, UTVR at 30 days 4.5% (P<0.004) 1.4% (P=ns) %events 12.8% 11.4% 8.3% The EPIC investigators. N. Engl J Med. 1994; 330: 956-961.

  2. 30 DayDeath/MI3.5% (P=0.015) 6 MonthDeath/MI3.9% (P=0.019) 30 DayTVR3.8% (P=0.003) 6 MonthTVR5.8% (P=0.007) Placebo + heparin (ACT  300 sec)(n=696) Abciximab + heparin (ACT  300 sec)(n=708) 22.3% MajorTIMIBleeding 16.5% 12.8% 9.6% 8.9% 7.8% 6.6% 6.1% 4.0% 1.4% EPIC Results %events The EPIC investigators. N. Engl J Med. 1994; 330: 956-961.

More Related